ADC Therapeutics
Innovating Science. Inspiring Hope.
266 employees · est. 2011 · Lausanne, Switzerland
ADC Therapeutics is the older company (2011 vs 2019); ADC Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | ADC Therapeutics | Mnemo Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2011 older | 2019 |
| Headquarters | ||
| Headquarters | Lausanne, Switzerland | Paris, France |
| Employees | ||
| Employees | 266 larger | 16 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health and Wellness | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Unknown | Series A |
| Total Funding | ||
| Total Funding | $1.27B | $75.00M |
| Funding Rounds | ||
| Funding Rounds | 13 | 3 |
| Services | ||
| Services | Development of Antibody Drug Conjugates, Expansion of Cancer Treatment Products, Clinical Trial Innovation, Medical Affairs and Research | Research and Development, Therapeutic Solutions, Scientific Publication Production |
| Target Customers | ||
| Target Customers | Patients with Hematologic Cancers, Patients with Solid Tumors, Individuals with Relapsed or Refractory Cancer, Healthcare Providers in Oncology | Medical Researchers, Biopharmaceutical Industries, Healthcare Providers |
| Taxonomy | ||
| Taxonomy | Antibody Drug Conjugates (ADCs), Oncology, Hematological Cancers, Solid Tumors, Clinical-Stage Drug Development, Commercialization, CD19-directed Therapies, ZYNLONTA®, Pyrrolobenzodiazepine (PBD) Technology, Relapsed Or Refractory Diffuse Large B-cell Lymphoma, PSMA-targeting ADC, Cancer Treatment, Pharmaceutical Manufacturing, Drug Discovery, Biotechnology Innovation | Immunotherapy, Cancer Detection, Cancer Treatment, Dark Genome, E-antigens, Cell Therapy, TCE (T-cell Engagers), ADC (antibody-drug Conjugates), Cancer Vaccines, Drug Discovery, EnfiniT Platform, Tumour-specific Targets, Therapeutic Modalities, In-silico Pipelines |
| Website | ||
| Website | adctherapeutics.com | mnemo-tx.com |
About ADC Therapeutics
ADC Therapeutics, based in Switzerland, is a commercial-stage global leader in antibody drug conjugates (ADCs), dedicated to transforming cancer treatment. Founded in 2011, the company's expertise spans clinical development to manufacturing. With a focus on pioneering the ADC sector, their approved...
About Mnemo Therapeutics
Mnemo Therapeutics, founded in 2019, is a pioneering Paris-based biotechnology company, committed to transforming the landscape of cancer immunotherapy. With the guiding slogan, "Empower the body, cure the disease", Mnemo focuses on boosting the body's natural ability to identify and destroy cancer...
We will tell you when either one moves
BounceWatch watches ADC Therapeutics and Mnemo Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ADC Therapeutics and Mnemo Therapeutics — by email.
Frequently Asked Questions
Compare ADC Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at ADC Therapeutics on 10 Jun 2026, and Mnemo Therapeutics on 17 Sep 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.